EP Patent

EP4132504A1 — Methods of treatment using antifolates and pharmaceutical formulations comprising antifolates

Assigned to Emphascience Inc · Expires 2023-02-15 · 3y expired

What this patent protects

Herein is disclosed, a method of treating a viral pulmonary infection, the method comprising administering to a subject in need thereof a therapeutically effective amount of an antifolate.

USPTO Abstract

Herein is disclosed, a method of treating a viral pulmonary infection, the method comprising administering to a subject in need thereof a therapeutically effective amount of an antifolate.

Drugs covered by this patent

Patent Metadata

Patent number
EP4132504A1
Jurisdiction
EP
Classification
Expires
2023-02-15
Drug substance claim
No
Drug product claim
No
Assignee
Emphascience Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.